Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03294863 · ClinicalTrials.gov registry record · NA
Effectiveness of Embrace Scar Therapy Device After Cutaneous Wound Closure
A NA study, sponsored by University of California, Davis.
- Terminated
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT03294863 is a NA study that was terminated before completion, run by University of California, Davis. The registered enrollment target is 49 participants.
The verdict
NCT03294863, a NA study, was terminated before completion, sponsored by University of California, Davis.
- TERMINATED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the use of the embrace device after repair of linear cutaneous surgery wounds improves scar cosmesis.
Interventions
- OTHER Standard of Care
- DEVICE Embrace Scar Therapy Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2017-03-15 |
| Est. Completion | 2025-12-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03294863
The ClinicalTrials.gov registry entry for NCT03294863 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT03294863 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03294863 about?
NCT03294863 is a clinical study titled "Effectiveness of Embrace Scar Therapy Device After Cutaneous Wound Closure". The purpose of this study is to determine whether the use of the embrace device after repair of linear cutaneous surgery wounds improves scar cosmesis.
What is the current status of trial NCT03294863?
This trial is currently terminated. It is a NA study. The enrollment target is 49 participants. The study started on 2017-03-15. Estimated completion is 2025-12-08.
What interventions are being tested in trial NCT03294863?
The interventions under investigation include: Standard of Care (OTHER), Embrace Scar Therapy Device (DEVICE).
Who is sponsoring clinical trial NCT03294863?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.